AMO Pharma reveals data from myotonic dystrophy study
Clinically significant results have emerged from trial evaluating the company’s AMO-02 candidate
Read More
Tag: trial
Ariceum doses first patient with satoreotide
The treatment targets extensive stage small cell lung cancer and aims to boost therapeutic impact
Read More
Neuroplast spinal cord injury study milestone
The trial analyses the impact of its ‘Neuro-Cells’ among patients with traumatic spinal cord injuries
Read More
Vitestro begins blood-drawing device study
Technology combines AI-based, ultrasound-guided 3D reconstruction with robotic needle insertion
Read More
EsoCap finalises recruitment for eosinophilic esophagitis study
Candidate ESO-101 will treat participating patients across five European countries
Read More
BenevolentAI doses participants in BEN-8744 study
The candidate is a peripherally restricted small-molecule PDE10 inhibitor to treat ulcerative colitis
Read More
Calliditas reveals results from vital NefIgArd study
The study concerns the use of Nefecon among adult patients with primary IgA nephropathy
Read More
Evgen releases data from SFX-01 trial
The study is specifically analysing the company’s new enteric coated tablet formation of the drug
Read More
CymaBay begins phase 3 liver disease study
IDEAL study aims to determine the impact of seladelpar on alkaline phosphatase levels
Read More
Taiho begins latest non-small cell lung cancer trial
A combination of zipalertinib and chemotherapy will be evaluated as a treatment for adults
Read More
First patient dosed in Immutep’s soft tissue sarcoma trial
The phase 2 study involves company’s eftilagimod alpha therapy
Read More
Crescendo widens pivotal solid tumour therapy trial
The CB307 study expansion involves the addition of a new pembrolizumab combination cohort
Read More
- MIT’s new MRI brain light-detecting technique could support brain cell studies
- PharmaTimes MSEA and NIEA awards are open for entry
- BBSRC invests £48m in Babraham Institute to advance lifelong health research
- NHS reduces long waits for cancer care and achieves faster ambulance responses
- MHRA’s AI Airlock to address challenges for regulating AI medical devices
